Durrant says lenz will be evaluated in the National Institute of Allergy and Infectious Diseases’ (NIAID) Big Effect Trial (BET) in patients hospitalized with COVID-19.
Humanigen chosen by National Institute of Health's upcoming coronavirus clinical trial
Quick facts: Humanigen, Inc.
Price: 4.95 USD
Market Cap: $625.39 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Humanigen, Inc. named herein, including the promotion by the Company of Humanigen, Inc. in any Content on the Site, the Company receives from...FOR OUR FULL DISCLAIMER CLICK HERE